Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae:: a case-control study in a district teaching hospital in Taiwan

被引:62
作者
Lin, MF
Huang, ML
Lai, SH
机构
[1] Hsing Chu Hsop, Dept Hlth, Dept Internal Med, Div Infect Dis, Hsinchu 300, Taiwan
[2] Hsing Chu Hsop, Dept Hlth, Nosocomial Infect Control Comm, Hsinchu 300, Taiwan
关键词
K; pneumoniae; ESBLs; risk factors; ceftazidime;
D O I
10.1053/jhin.2002.1331
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A case-control study was performed to find the risk factors in the acquisition of extended-spectrum P-lactamase (ESBL) Klebsiella pneumoniae. From 1 May 2001 to 30 September 2001, 422 isolates of K. pneumoniae identified by the microbiological laboratory in Hsin-Chu hospital were collected, 59 of which were ESBL-producing strains. The prevalence rate was 14% (59/422). There were 43 case patients (ESBL-producing K. pneumoniae) and 86 controls (non-ESBL-producing K. pneumoniae). Tracheostomy, insertion of a Foley catheter, endotracheal tube, nasogastric tube and central venous catheter were found to be risk factors in the acquisition of K. pneumoniae with ESBLs by univariate analysis. Tracheostomy (odds ratio, 5.13; 95% Cl, 1.24-21.1; P = 0.023) and ceftazidime use (odds ratio, 13.40; 95% CI, 1.21-148.85; P = 0.035) remained as risk factors by multivariate analysis with logistic regression. Other anti-pseudomonal agents should be used as empirical therapy to treat possible Pseudomonas aeruginosa infection in order to reduce ceftazidime use and thereby decrease the prevalence of ESBL producing strains of Enterobacteriaceae. (C) 2003 The Hospital Infection Society.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 35 条
[11]  
Jan IS, 1998, J FORMOS MED ASSOC, V97, P661
[12]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[13]   DETECTION OF KLEBSIELLA-PNEUMONIAE AND ESCHERICHIA-COLI STRAINS PRODUCING EXTENDED-SPECTRUM BETA-LACTAMASES [J].
KATSANIS, GP ;
SPARGO, J ;
FERRARO, MJ ;
SUTTON, L ;
JACOBY, GA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (03) :691-696
[14]   TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS [J].
KNOTHE, H ;
SHAH, P ;
KRCMERY, V ;
ANTAL, M ;
MITSUHASHI, S .
INFECTION, 1983, 11 (06) :315-317
[15]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes [J].
Lautenbach, E ;
Patel, JB ;
Bilker, WB ;
Edelstein, PH ;
Fishman, NO .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1162-1171
[16]   Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan [J].
Liu, PYF ;
Tung, JC ;
Ke, SC ;
Chen, SL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) :2759-2762
[17]   Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp from intensive care units in Europe [J].
Livermore, DM ;
Yuan, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) :409-424
[18]   Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition [J].
Lucet, JC ;
Chevret, S ;
Decre, D ;
Vanjak, D ;
Macrez, A ;
Bedos, JP ;
Wolff, M ;
Regnier, B .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (03) :430-436
[20]  
Menashe G, 2001, SCAND J INFECT DIS, V33, P188, DOI 10.1080/00365540151060806